Meet with the men and women who are leading efforts to improve the quality and efficiency of our healthcare system. Talk with thought leaders who craft policy at the state and federal level. Engage with life sciences entrepreneurs who are discovering and commercializing products that can extend and improve our lives.
The Colloquium in Healthcare Leadership brings prominent leaders from public, private, and nonprofit healthcare organizations to campus for candid discussions. You will deepen your understanding of the major trends in healthcare as well as the challenges of being a leader in this space.
Thursday Evening Series - 6:30 PM, Beaumont Room, Sterling Hall of Medicine (2nd Floor), 333 Cedar Street
September 3, 2020 -- Introduction to Colloquium In Healthcare Leadership
Howard P. Forman, MD, MBA
Director, YSPH Health Care Management Program
Director, MD/MBA Program
Professor of Radiology & Public Health (Health Policy)
Professor in the Practice of Management
Professor of Economics (joint by courtesy)
Faculty Director, Executive MBA Program (Healthcare)
September 10, 2020
Jerome H. Kim, MD, Director General, The International Vaccine Institute
Jerome H. Kim
International Vaccine Institute
Jerome Kim, M.D., is the Director General of the International Vaccine Institute (IVI) and an international expert on the evaluation and development of vaccines. His depth and breadth of scientific experience span basic research through advanced clinical development. IVI’s oral cholera vaccine is used around the world to prevent this deadly diarrheal disease. IVI’s typhoid conjugate vaccine, tech-transferred to SK bioscience and PT Bio Farma, is completing Phase III testing. IVI is working on several different vaccines against COVID-19, including the clinical testing of Inovio’s DNA vaccine at Seoul National University Hospital and Genexine’s COVID-19 vaccine at Severance Hospital.
Dr. Kim was Principal Deputy and Chief, Laboratory of Molecular Virology and Pathogenesis ,in the U.S. Military HIV Research Program (MHRP) and also served as the Project Manager for the HIV Vaccines and Advanced Concepts Evaluation Project Management Offices, U.S. Army Medical Materiel Development Activity, Fort Detrick, MD. He led the Army's Phase III HIV vaccine trial (RV144) which was the first demonstration that an HIV vaccine could protect against infection, as well as subsequent studies that identified laboratory correlates and HIV sequence changes associated with vaccination.
Dr. Kim has authored over 250 publications and received the John Maher Award for Research Excellence from the Uniformed Services University of the Health Sciences in 2013 and the Department of the Army R&D Award for Technical Excellence (2013). Dr. Kim is also an Adjunct Professor of Medicine at the Uniformed Services University of the Health Sciences and at Yonsei University Graduate School of Public Health and a Fellow of the American College of Physicians and the Infectious Diseases Society of America.
He is a graduate of the University of Hawaii, with high honors in History and highest honors in Biology, and received his M.D. from Yale University School of Medicine.
September 17, 2020
Marna P. Borgstrom, MPH (’79), CEO and President, Yale New Haven Hospital and Yale New Haven Health Systems
Marna P. Borgstrom
Chief Executive Officer, Yale New Haven Health and Yale New Haven Hospital
Marna Borgstrom has served as the Chief Executive Officer of Yale New Haven Hospital and Yale New Haven Health since 2005. With revenues of $5.5B, Yale New Haven Health is the largest health system in the region and largest employer in Connecticut. Marna began her career at Yale-New Haven Hospital over 40 years ago and served in a variety of staff and operational roles prior to her current positions.
Marna chairs the boards of the Healthcare Institute and the Coalition to Protect America’s Healthcare and is the past chair of Vizient, a Dallas, Texas-based health care company. She serves on several other boards including the American Hospital Association, the Connecticut Hospital Association and New Haven Promise. She is also a director of Cryolife in Atlanta, GA.
Marna has been recognized for her commitment to community service and the health care field with numerous awards. She also holds five honorary doctorate degrees.
Marna received her undergraduate degree from Stanford University and was awarded a master’s of public health by the Yale University School of Epidemiology and Public Health. She is a lecturer at the Yale School of Epidemiology and Public Health, from which she received the Distinguished Alumni Award in 2018.
September 24, 2020
Bio to come.
October 1st, 2020
Kevin B. Churchwell, MD, President/COO, Executive VP of Health Affairs, Boston Children's Hospital
Kevin B. Churchwell, M.D.
President and Chief Operating Officer
Boston Children’s Hospital
Dr. Churchwell brings over 25 years of experience as a clinician, researcher, hospital executive and administrator, as well as a valuable perspective in designing and implementing patient treatments. He currently serves as president and chief operating officer at Boston Children’s Hospital where he has been since August 2013. He is also the Robert and Dan Smith Associate Professor of Anesthesia at Harvard Medical School. Previously, he served as chief executive officer of Nemours/Alfred I. DuPont Hospital for Children from 2010 to 2013 and as chief executive officer and executive director for the Monroe Carrell Jr. Children’s Hospital, part of the Vanderbilt University Medical Center, from 2007 to 2010. Dr. Churchwell has been a clinician and faculty member at Boston Children’s Hospital and Vanderbilt University Medical Center since 1993. Dr. Churchwell graduated with a B.S. in Biology from the Massachusetts Institute of Technology and received his M.D. from Vanderbilt Medical School.
October 8th, 2020
Eric Golding, MD, MBA ('05), Manager, Healthcare/Life Sciences Portfolio (Private Entity) (Former Vice President, Consonance Capital)
Eric M. Golding, M.D., M.B.A.
Dr. Golding is a physician by training with investment experience in both the private and public markets. He currently manages the healthcare/life sciences portfolio for a large family office.
Previously, he worked at Consonance Capital, a healthcare-only long/short public equity fund specializing in biopharmaceuticals, medical devices, diagnostics, and healthcare IT. Prior to joining Consonance, Dr. Golding worked in venture capital investing at F-Prime Capital Partners (formerly known as Fidelity Biosciences), a global venture capital firm specializing in biotechnology, pharmaceuticals, medical devices, diagnostics, and healthcare services/IT. While at F-Prime, Dr. Golding was a Board Observer for Iora Health, an IT-enabled healthcare services company focused on building and operating de novo primary care practices. He was also a Board Observer for Symbiomix Therapeutics, a company focused on developing therapeutics in the area of women’s health (acquired by Lupin).
Dr. Golding completed his training in Internal Medicine at Beth Israel Deaconess Medical Center, an affiliate of Harvard Medical School. He gained insight into the area of pharmaceutical regulation through an internship at the Food and Drug Administration in the Office of Regulatory Policy. He holds an MD from the Yale School of Medicine and an MBA from the Yale School of Management. He received a BA from the University of Pennsylvania, where he graduated summa cum laude.
October 29th, 2020
Sara Nayeem, MD, MBA ('06), Partner, NEA Venture Capital
Sara Nayeem, M.D. is a Partner at New Enterprise Associates (NEA), a large diversified venture capital firm. Sara joined NEA's healthcare team in 2009 and focuses on investments in biopharmaceutical companies. She serves on the boards of Centrexion, Cydan, Imara (IMRA), Tiburio, and a stealth targeted oncology company. She previously served on the boards of Vtesse (acquired by Sucampo), Mersana (MRSN), Therachon (acquired by Pfizer), and Complexa, and as a board observer for Loxo Oncology (LOXO, acquired by Lilly), Tesaro (TSRO, acquired by GlaxoSmithKline), Clementia (CMTA, acquired by Ipsen), Nightstar (NITE, acquired by Biogen), Ziarco (acquired by Novartis), Omthera (OMTH, acquired by AstraZeneca), Epizyme (EPZM), Millendo (MLND) and Zyngenia.
She also serves on the boards of the New England Venture Capital Association and BioHealth Innovation Management, and on the Advisory boards of Incubate Coalition and No Patient Left Behind. She was included on Fierce Biotech’s 2019 list of the Fiercest Women in Life Sciences and was selected three times as one of GrowthCap’s Top 40 Under 40 Growth Investors.
Prior to joining NEA, Sara was an investing banking Associate with Merrill Lynch’s Global Healthcare Group, and previously, she worked as an investment banking Analyst at Morgan Stanley.
Sara concurrently earned her MD (cum laude) and MBA from Yale University, where she was a Yale MBA Scholar. She received her AB (magna cum laude) in Biology from Harvard University.
November 19, 2020
Carolyn M. Clancy, MD, Deputy Under Secretary for Health for Discovery, Education and Affiliate Networks (DEAN), U.S. Department of Veterans’ Affairs
Carolyn Clancy, M.D., MACP
Assistant Under Secretary for Health, Discovery, Education & Affiliate Networks, Veterans Health Administration
Dr. Clancy serves as the Assistant Under Secretary for Health (AUSH) for Discovery, Education & Affiliate Networks (DEAN), Veterans Health Administration (VHA), effective July 22, 2018. The Office of the DEAN fosters collaboration and knowledge transfer with facility-based educators, researchers and clinicians within VA, and between VA and its affiliates.
Prior to her current position, she served as the VHA Executive in Charge, with the authority to perform the functions and duties of the Under Secretary for Health. As the Executive in Charge, Dr. Clancy directed a health care system with an annual budget of approximately $68 billion, overseeing the delivery of care to more than 9 million enrolled Veterans. Previously, she served as the Interim Under Secretary for Health from 2014-2015. Dr. Clancy also served as the VHA AUSH for Organizational Excellence, overseeing VHA’s performance, quality, safety, risk management, systems engineering, auditing, oversight, ethics and accreditation programs, as well as ten years as the Director, Agency for Healthcare Research and Quality.
She is a highly experienced and nationally recognized physician executive. Dr. Clancy is a general internist and health services researcher, a graduate of Boston College and the University of Massachusetts Medical School. She holds an academic appointment at George Washington University’s School of Medicine and serves as Senior Associate Editor, Health Services Research Journal. She has contributed to eight academic text books and authored, co-authored and provided invited commentary in more than 225 scholarly journal articles. She served as member of the National Quality Forum’s Board of Directors, Chair of the AQA Alliance and served on the Board of Governors for the Patient-Centered Outcomes Research Institute. She is an elected member of the National Academy of Medicine and was presented with the 2014 Quality Champion Award from the National Committee for Quality Assurance. She was also named as an Honorary Fellow of the American Academy of Nursing and was selected as the 2015 Outstanding Federal Executive of the Year by Disabled American Veterans. In 2018, she was selected as one of the Top 50 Physician Executives by Modern Healthcare, and in 2019, she was identified as one of the 50 Most Influential Clinical Executives by Modern Healthcare.
2018 – Present Assistant Under Secretary for Health, Discovery, Education & Affiliate Networks, Washington, DC
2017 – 2018 Executive in Charge, Veterans Health Administration, Washington, DC
2015 – 2017 Deputy Under Secretary for Health for Organizational Excellence, VHA, Washington, DC
2015 Chief Medical Officer, VHA, Washington, DC
2014 – 2015 Interim Under Secretary for Health, VHA, Washington, DC
2013 – 2014 Assistant Deputy Under Secretary for Health for Quality, Safety & Value, Washington, DC
2003 – 2013 Director, Agency for Healthcare Research and Quality (AHRQ), Washington, DC
1984 Henry J. Kaiser Family Foundation Fellow in General Internal Medicine, University of Pennsylvania
1982 Intern and Resident in Medicine, Worcester Memorial Hospital, Worcester, MA
1979 Medical Doctor, University of Massachusetts School of Medicine, Amherst, MA
1975 Bachelor of Science in Math and Chemistry, Boston College, Chestnut Hill, MA
December 3rd, 2020
Pamela Sutton-Wallace, MPH, Senior Vice President & Regional Chief Operating Officer, New York Presbyterian Hospital
Pamela Sutton-Wallace is an accomplished and distinguished health care executive with more than 25 years of experience in various sectors of the health care industry. Currently, Pam serves as Senior Vice President and Regional Chief Operating Officer at New York Presbyterian. In this capacity, she is responsible for strategic operations in the Brooklyn and Queens markets and oversees the NYP Physician Services division.
Prior to her appointment at NYP, Pam served as the Chief Executive Officer for the University of Virginia (UVA) Medical Center in Charlottesville, Virginia from 2014-2020. Overseeing a $2.2B budget, she strategically led UVA Health in receiving several national recognitions in quality, safety, patient experience and team member engagement.
While at Duke University Hospital in Durham North Carolina for 17 years, Pam served in several leadership positions including: Senior Vice President for Hospital Operations, Chief Operating Officer for Ambulatory Services, Vice President for Perioperative Services and Chief of Staff to the Chancellor for Health Affairs. Pam has also held positions in the pharmaceutical and insurance industries at Pfizer and Blue Cross & Blue Shield of North Carolina, respectively.
She received her undergraduate degree in Political Science and African-American Studies from Washington University in St. Louis, MO. She later graduated from Yale University with a Master of Public Health (MPH) degree, completing her thesis with distinction.
Pam has served on several professional and community boards including the Duke University School of Nursing Board of Visitors, America’s Essential Hospitals, American Hospital Association Region 3 Policy Board, Virginia Hospital and Healthcare Association, Charlottesville Regional Chamber of Commerce and the Charlottesville Area Community Foundation (CACF) to name a few. With her 27 years of healthcare experience at some of the world's most renowned health systems, Ms. Sutton-Wallace brings valuable expertise and perspective to J2 Global's Board.
February 11, 2021
Prathiba Varkey, MBBS, MPH, MHPE, MBA, President and CEO, Northeast Medical Group Senior Vice President, Yale New Haven Health
Bio to come.
February 25, 2021
Susan Chapman Moss, MPH (’99), Senior Vice President, Payer Contracting & System Planning, Mass General Brigham
Bio to come.
March 4, 2021
Rahul Rajkumar, MD (’04), JD (’06), Chief Operating Officer, Care Solutions at Optum
Bio to come.